JAC-Antimicrobial Resistance

JAC-Antimicrobial Resistance

A novel therapy combines rifaximin and clarithromycin for treating Mycobacterium abscessus

Rifaximin enhances clarithromycin's effectiveness against Mycobacterium abscessus.

Recent Stories